MRI scan tests new markers for head and neck cancers
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests special MRI scans to find warning signs of cancer that has returned or spread in the head and neck area. It may help doctors see these changes more clearly, which could improve treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have suspected or confirmed cancer that is either recurring or metastatic in the head and neck area
- Plan to receive treatment at Memorial Sloan Kettering (MSK)
- Be able to safely complete MRI without needing anesthesia
- Not be pregnant and be able to cooperate during the MRI scan
- Not have certain MRI safety issues (example: pacemaker, metal clips/implants that are unsafe for MRI) and not have a known allergy to gadolinium contrast
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying how MRI images can help predict response to a combination of chemotherapy and immunotherapy before surgery for head and neck cancer. It aims to improve treatment planning for patients with this type of cancer.
This trial tests a “master protocol” approach to use MRI (a detailed body scan) to help plan radiation treatment for people with cancer. It may help doctors customize radiation more accurately, depending on your specific cancer type.
This trial tests a new way to deliver radiation therapy using an MRI machine to guide the treatment for head and neck cancers. It may help patients who are not candidates for standard curative treatment due to age, health issues, or advanced disease.
This study tests MRI scanning and image analysis methods to help doctors plan radiation treatment more accurately and assess how well it’s working. You might help improve how MRI is used for radiation planning and follow-up.
This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.
This study uses repeat MRI scans to look for imaging “markers” that may help doctors better understand head and neck squamous cell cancer. It may be most relevant if you are planning curative surgery and/or (chemo)radiotherapy and can safely undergo MRI more than once.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.